Journal of Autism and Developmental Disorders

, Volume 38, Issue 2, pp 324–332 | Cite as

Are There Enhanced MBP Autoantibodies in Autism?

  • Jane E. Libbey
  • Hilary H. Coon
  • Nikki J. Kirkman
  • Thayne L. Sweeten
  • Judith N. Miller
  • Edward K. Stevenson
  • Janet E. Lainhart
  • William M. McMahon
  • Robert S. Fujinami
Original Paper

Abstract

Autoantibodies to central nervous system antigens, such as myelin basic protein (MBP), may play a role in autism. We measured autoantibody titers to MBP in children with autism, both classic onset and regressive onset forms, controls (healthy age- and gender-matched) and individuals with Tourette syndrome via enzyme-linked immunosorbent assays. We found a significant difference in autoantibody titers to MBP, not accounted for by age or medication, between Tourette and classic autism (both significantly lower) when compared to regressive autism, but not when compared to controls. Autoantibody responses against MBP are unlikely to play a pathogenic role in autism.

Keywords

Autism Tourette syndrome Autoantibody Myelin basic protein Immunoglobulin 

References

  1. Alexander, A. L., Lee, J. E., Lazar, M., Boudos, R., Dubray, M. B., Oakes, T. R., Miller, J. N., Lu, J., Jeong, E. K., McMahon, W. M., Bigler, E. D., & Lainhart, J. E. (2007). Diffusion tensor imaging of the corpus callosum in Autism. Neuroimage, 34, 61–73.PubMedCrossRefGoogle Scholar
  2. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4th ed.), Text Revision. Washington, DC.Google Scholar
  3. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychology of Medicine, 25, 63–77.CrossRefGoogle Scholar
  4. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M., & Lantos, P. (1998). A clinicopathological study of autism. Brain, 121, 889–905.PubMedCrossRefGoogle Scholar
  5. Barnea-Goraly, N., Kwon, H., Menon, V., Eliez, S., Lotspeich, L., & Reiss, A. L. (2004). White matter structure in autism: Preliminary evidence from diffusion tensor imaging. Biological Psychiatry, 55, 323–326.PubMedCrossRefGoogle Scholar
  6. Boger-Megiddo, I., Shaw, D. W., Friedman, S. D., Sparks, B. F., Artru, A. A., Giedd, J. N., Dawson, G., & Dager, S. R. (2006). Corpus callosum morphometrics in young children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 36, 733–739.PubMedCrossRefGoogle Scholar
  7. Borenstein, M., Rothstein, H., & Cohen, J. (2000). Power and Precision, version 2.0. www.PowerAndPrecision.com.Google Scholar
  8. Chakrabarti, S., & Fombonne, E. (2001). Pervasive developmental disorders in preschool children. Journal of the American Medical Association, 285, 3093–3099.PubMedCrossRefGoogle Scholar
  9. Chung, M. K., Dalton, K. M., Alexander, A. L., & Davidson, R. J. (2004). Less white matter concentration in autism: 2D voxel-based morphometry. Neuroimage, 23, 242–251.PubMedCrossRefGoogle Scholar
  10. Coleman, M., & Gillberg, C. (1985). The biology of the autistic syndromes. New York: Praeger Publishers.Google Scholar
  11. Connolly, A. M., Chez, M., Streif, E. M., Keeling, R. M., Golumbek, P. T., Kwon, J. M., Riviello, J. J., Robinson, R. G., Neuman, R. J., & Deuel, R. M. K. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau–Kleffner syndrome, and epilepsy. Biological Psychiatry, 59, 354–363.PubMedCrossRefGoogle Scholar
  12. Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999). Serum autoantibodies to brain in Landau–Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134, 607–613.PubMedCrossRefGoogle Scholar
  13. Courchesne, E., Karns, C. M., Davis, H. R., Ziccardi, R., Carper, R. A., Tigue, Z. D., Chisum, H. J., Moses, P., Pierce, K., Lord, C., Lincoln, A. J., Pizzo, S., Schreibman, L., Haas, R. H., Akshoomoff, N. A., & Courchesne, R. Y. (2001). Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology, 57, 245–254.PubMedGoogle Scholar
  14. Deibler, G. E., Martenson, R. E., & Kies, M. W. (1972). Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Preparative Biochemistry, 2, 139–165.PubMedCrossRefGoogle Scholar
  15. Detskey, P. Z., Bigbee, J. W., & DeVries, G. H. (1988). Isolation and characterization of axolemma-enriched fractions from discrete areas of bovine CNS. Neurochemical Research, 13, 449–454.PubMedCrossRefGoogle Scholar
  16. Egaas, B., Courchesne, E., & Saitoh, O. (1995). Reduced size of corpus callosum in autism. Archives of Neurology, 52, 794–801.PubMedGoogle Scholar
  17. Filipek, P. A. (1996). Brief report: neuroimaging in autism: The state of the science 1995. Journal of Autism and Developmental Disorders, 26, 211–215.PubMedCrossRefGoogle Scholar
  18. Fombonne, E. (2003). The prevalence of autism. Journal of the American Medical Association, 289, 87–89.PubMedCrossRefGoogle Scholar
  19. Fujinami, R. S., Zurbriggen, A., & Powell, H. C. (1988). Monoclonal antibody defines determinant between Theiler’s virus and lipid-like structures. Journal of Neuroimmunology, 20, 25–32.PubMedCrossRefGoogle Scholar
  20. Gillberg, C., & Wing, L. (1999). Autism: Not an extremely rare disorder. Acta Psychiatra Scandinavica, 99, 399–406.CrossRefGoogle Scholar
  21. Goldberg, W. A., Osann, K., Filipek, P. A., Laulhere, T., Jarvis, K., Modahl, C., Flodman, P., & Spence, M. A. (2003). Language and other regression: Assessment and timing. Journal of Autism and Developmental Disorders, 33, 607–616.PubMedCrossRefGoogle Scholar
  22. Hardan, A. Y., Minshew, N. J., & Keshavan, M. S. (2000). Corpus callosum size in autism. Neurology, 55, 1033–1036.PubMedGoogle Scholar
  23. Herbert, M. R., Ziegler, D. A., Makris, N., Filipek, P. A., Kemper, T. L., Normandin, J. J., Sanders, H. A., Kennedy, D. N., & Caviness, V. S., Jr. (2004). Localization of white matter volume increase in autism and developmental language disorder. Annals of Neurology, 55, 530–540.PubMedCrossRefGoogle Scholar
  24. Husted, C. (2006). Structural insight into the role of myelin basic protein in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 103, 4339–4340.PubMedCrossRefGoogle Scholar
  25. Jankovic, J. (2001). Tourette’s syndrome. New England Journal of Medicine, 345, 1184–1192.PubMedCrossRefGoogle Scholar
  26. Just, M. A., Cherkassky, V. L., Keller, T. A., & Minshew, N. J. (2004). Cortical activation and synchronization during sentence comprehension in high-functioning autism: Evidence of underconnectivity. Brain, 127, 1811–1821.PubMedCrossRefGoogle Scholar
  27. Kirkman, N. K., Libbey, J. E., Sweeten, T. L., Coon, H. H., Miller, J. N., Stevenson, E. K., Lainhart, J. E., McMahon, W. M., & Fujinami, R. S. (in press). How relevant are GFAP autoantibodies in autism? Journal of Autism and Developmental Disorders.Google Scholar
  28. Kiessling, L. S., Marcotte, A. C., & Culpepper, L. (1993). Antineuronal antibodies in movement disorders. Pediatrics, 92, 39–43.PubMedGoogle Scholar
  29. Lainhart, J. E., Bigler, E. D., Bocian, M., Coon, H., Dinh, E., Dawson, G., Deutsch, C. K., Dunn, M., Estes, A., Tager-Flusberg, H., Folstein, S., Hepburn, S., Hyman, S., McMahon, W., Minshew, N., Munson, J., Osann, K., Ozonoff, S., Rodier, P., Rogers, S., Sigman, M., Spence, M. A., Stodgell, C. J., & Volkmar, F. (2006). Head circumference and height in autism: A study by the collaborative program of excellence in autism. American Journal of Medical Genetics Part A, 140, 2257–2274.PubMedCrossRefGoogle Scholar
  30. Luyster, R., Richler, J., Risi, S., Hsu, W.-L., Dawson, G., Bernier, R., Dunn, M., Hepburn, S., Hyman, S. L., McMahon, W. M., Goudie-Nice, J., Minshew, N., Rogers, S., Sigman, M., Spence, M. A., Goldberg, W. A., Tager-Flusberg, H., Volkmar, F. R., & Lord, C. (2005). Early regression in social communication in autism spectrum disorders: A CPEA Study. Developmental Neuropsychology, 27, 311–336.PubMedCrossRefGoogle Scholar
  31. Manes, F., Piven, J., Vrancic, D., Nanclares, V., Plebst, C., & Starkstein, S. E. (1999). An MRI study of the corpus callosum and cerebellum in mentally retarded autistic individuals. Journal of Neuropsychiatry and Clinical Neurosciences, 11, 470–474.PubMedGoogle Scholar
  32. Minshew, N. J., Goldstein, G., & Siegel, D. J. (1997). Neuropsychologic functioning in autism: profile of a complex information processing disorder. Journal of the International Neuropsychological Society, 3, 303–316.PubMedGoogle Scholar
  33. Musse, A. A., Boggs, J. M., & Harauz, G. (2006). Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proceedings of the National Academy of Sciences of the United States of America, 103, 4422–4427.PubMedCrossRefGoogle Scholar
  34. Nelson, K. B. (1991). Prenatal and perinatal factors in the etiology of autism. Pediatrics, 87, 761–766.PubMedGoogle Scholar
  35. Piven, J., Bailey, J., Ranson, B. J., & Arndt, S. (1997). An MRI study of the corpus callosum in autism. American Journal of Psychiatry, 154, 1051–1056.PubMedGoogle Scholar
  36. Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (1994). Immunoglobin reactivity in autism and Rett’s syndrome. Developmental Brain Dysfunction, 7, 12–16.Google Scholar
  37. Sambrook, J., Fritsch, E. F., & Maniatis, T. (1989). Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory.Google Scholar
  38. Schotte, A., Janssen, P. F., Megens, A. A., & Leysen, J. E. (1993). Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research, 631, 191–202.PubMedCrossRefGoogle Scholar
  39. Singer, H. S., Giuliano, J. D., Hansen, B. H., Hallett, J. J., Laurino, J. P., Benson, M., & Kiessling, L. S. (1998). Antibodies against human putamen in children with Tourette’s syndrome. Neurology, 50, 1618–1624.PubMedGoogle Scholar
  40. Singer, H. S., Morris, C. M., Williams, P. N., Yoon, D. Y., Hong, J. J., & Zimmerman, A. W. (2006). Antibrain antibodies in children with autism and their unaffected siblings. Journal of Neuroimmunology, 178, 149–155.PubMedCrossRefGoogle Scholar
  41. Singh, V. K., Lin, S. X., Newell, E., & Nelson, C. (2002). Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. Journal of Biomedical Science, 9, 359–364.PubMedCrossRefGoogle Scholar
  42. Singh, V. K., Lin, S. X., & Yang, V. C. (1998). Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clinical Immunology and Immunopathology, 89, 105–108.PubMedCrossRefGoogle Scholar
  43. Singh, V. K., & Rivas, W. H. (2004). Prevalence of serum antibodies to caudate nucleus in autistic children. Neuroscience Letters, 355, 53–56.PubMedCrossRefGoogle Scholar
  44. Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997). Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology, 17, 88–90.PubMedCrossRefGoogle Scholar
  45. Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior and Immunity, 7, 97–103.CrossRefGoogle Scholar
  46. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Lougee, L., Dow, S., Zamkoff, J., & Dubbert, B. K. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. American Journal of Psychiatry, 155, 264–271.PubMedGoogle Scholar
  47. Tolley, N. D., Tsunoda, I., & Fujinami, R. S. (1999). DNA vaccination against Theiler’s murine encephalomyelitis virus leads to alterations in demyelinating disease. Journal of Virology, 73, 993–1000.PubMedGoogle Scholar
  48. Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67–81.PubMedCrossRefGoogle Scholar
  49. Vidal, C. N., Nicolson, R., DeVito, T. J., Hayashi, K. M., Geaga, J. A., Drost, D. J., Williamson, P. C., Rajakumar, N., Sui, Y., Dutton, R. A., Toga, A. W., & Thompson, P. M. (2006). Mapping corpus callosum deficits in autism: an index of aberrant cortical connectivity. Biological Psychiatry, 60, 218–225.PubMedCrossRefGoogle Scholar
  50. Vojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002). Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. Journal of Neuroimmunology, 129, 168–177.PubMedCrossRefGoogle Scholar
  51. Waiter, G. D., Williams, J. H., Murray, A. D., Gilchrist, A., Perrett, D. I., & Whiten, A. (2005). Structural white matter deficits in high-functioning individuals with autistic spectrum disorder: A voxel-based investigation. Neuroimage, 24, 455–461.PubMedCrossRefGoogle Scholar
  52. Yamada, M., Zurbriggen, A., Oldstone, M. B. A., & Fujinami, R. S. (1991). Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. Journal of Virology, 65, 1370–1376.PubMedGoogle Scholar
  53. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. Journal of the American Medical Association, 289, 49–55.PubMedCrossRefGoogle Scholar
  54. Yeh, C.-B., Wu, C.-H., Tsung, H.-C., Chen, C.-W., Shyu, J.-F., & Leckman, J. F. (2006). Antineural antibody in patients with Tourette’s syndrome and their family members. Journal of Biomedical Science, 13, 101–112.PubMedCrossRefGoogle Scholar
  55. Zimmerman, A. W., Connors, S. L., Matteson, K. J., Lee, L. C., Singer, H. S., Castaneda, J. A., & Pearce, D. A. (2007). Maternal antibrain antibodies in autism. Brain Behavior and Immunity, 21, 351–357.CrossRefGoogle Scholar
  56. Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005). Cerebrospinal fluid and serum markers of inflammation in autism. Pediatric Neurology, 33, 195–201.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Jane E. Libbey
    • 1
  • Hilary H. Coon
    • 2
  • Nikki J. Kirkman
    • 1
  • Thayne L. Sweeten
    • 1
  • Judith N. Miller
    • 2
  • Edward K. Stevenson
    • 1
  • Janet E. Lainhart
    • 2
  • William M. McMahon
    • 2
  • Robert S. Fujinami
    • 1
  1. 1.Department of NeurologyUniversity of UtahSalt Lake CityUSA
  2. 2.Department of PsychiatryUniversity of UtahSalt Lake CityUSA

Personalised recommendations